The CDMO/CMO Report: Parenteral Drugs

11/16/22 • 30 min

DCAT Value Chain Insights’ Production to Prescription

Increased demand in biologic-based drug development is a key factor driving demand for parenteral drug manufacturing. What are key trends and expansions by CDMO/CMOs in parenteral drug manufacturing? DCAT Value Chain Insights rounds up the latest developments among CDMO/CMOs. For the text version of this article visit dcatvci.org.

Key topics: (see Chapter Markers in drop down menu in audio player above)

Recent expansion projects
Baxter BioPharma Solutions
Vetter
Recipharm
WuXi STA
Jubilant HollisterStier
PCI Pharma Services
Grand River Aseptic Manufacturing
Catalent
Thermo Fisher Scientific
Lonza
Carbogen Amcis
Alcami
Delpharm
Fareva
WuXi Biologics
IDT Biologika
Emergent CDMO
BSP Pharmaceuticals
Aenova
Samsung Biologics
Ajinomoto Bio-Pharma Services
Selkirk Pharma
INCOG BioPharma Services
ten23 health
Berkshire Sterile Manufacturing

Sponsor: Vetter Pharma International GmbH

Links:

Subscribe to our e-newsletter at www.dcatvci.org

Support the show

Key topics: (see Chapter Markers in drop down menu in audio player above)

Recent expansion projects
Baxter BioPharma Solutions
Vetter
Recipharm
WuXi STA
Jubilant HollisterStier
PCI Pharma Services
Grand River Aseptic Manufacturing
Catalent
Thermo Fisher Scientific
Lonza
Carbogen Amcis
Alcami
Delpharm
Fareva
WuXi Biologics
IDT Biologika
Emergent CDMO
BSP Pharmaceuticals
Aenova
Samsung Biologics
Ajinomoto Bio-Pharma Services
Selkirk Pharma
INCOG BioPharma Services
ten23 health
Berkshire Sterile Manufacturing

Sponsor: Vetter Pharma International GmbH

Links:

Subscribe to our e-newsletter at www.dcatvci.org

Support the show

Previous Episode

Drug Products: Key Trends & Recent Approvals

What are noteworthy trends in drug delivery and drug-product development in key dosage forms: solid dosage and parenteral drugs? A look at key technology advances and recent new drug approvals. For the text version of this article visit dcatvci.org.

Key topics: (see Chapter Markers in drop down menu in audio player above)

Recent trends: new drug approvals
Technology advances
Enable Injections’ on-body subcutaneous drug-delivery system
Lilly’s and Triastek’s pact for 3-D printing for oral drug delivery
Multifunctional wireless robots in drug delivery
Advances in implantable devices for drug delivery

Sponsor: Vetter Pharma International GmbH

Links:

Subscribe to our e-newsletter at www.dcatvci.org

Support the show

Next Episode

API Alert: EU Proposes New Requirements To Secure Pharma Supply Chains

The European Commission has issued its long-awaited proposal to reform pharmaceutical legislation in the EU, the first major overhaul in 20 years, which includes new requirements to address drug shortages and secure supply chains. For the text version of this article visit dcatvci.org.Key topics: (see Chapter Markers in drop down menu in audio player above)